Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Shin Kawano
Chief Scientist at iBody Inc
Speaker

Profile

Dr. Shin Kawano received a Ph.D. in Biology with a specialization in Structural Biology from Kyushu University. His doctoral research focused on the structural and functional analysis of proteins and biomolecular interactions. Following academic research in structural biology and molecular biology, Dr. Kawano joined iBody Inc., where he currently serves as Chief Scientist. His work focuses on antibody discovery, engineering, and development for research and therapeutic applications. Dr. Kawano's research interests include antibody technologies, protein engineering, and the application of structural biology to biologics discovery and development.

Agenda Sessions

  • Marriage of single-cell and cell-free technologies for rapid and comprehensive generation of high-performance antibodies

    12:30